HAEGARDA®

Haegarda®

FDA INDICATION: For routine prophylaxis to prevent hereditary angioedema (HAE) attacks in adolescent and adult patients Package Insert

FORM: Lyophilized

DISTRIBUTOR: CSL Behring

ROUTE OF ADMINISTRATION: Subcutaneous

DOSAGE STRENGTH: 2000, 3000 Units

DILUENT SIZE: 4.0 mL (2000 IU), 6.0 mL (3000 IU)

MIXING DEVICE: Mix2Vial®

SELF-ADMINISTRATION: Yes, after teaching

STORAGE: When stored at temperatures up to 30°C (86°F), product is stable for the period indicated by the expiration date on the carton and vial label. Keep in its original carton until ready to use. Do not freeze. Protect from light.

HALF-LIFE: 69 hours

OTHER WEBSITES: allabouthae.comhaegarda.com